Long-term compromised immune regulation after rituximab induction in blood group incompatible (ABOi) living-donor renal transplantation – 5 year results of a prospective pilot study
BackgroundAn increased risk of severe infectious disease and acute antibody-mediated rejection (AMR) has been described after ABOi renal transplantation. We performed a prospective renal transplant study up to 5 years posttransplant to detect long-term…